Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents

Oncology Reports

Volumn 25, Issue 4, 2011, Pages 1177-1181

  Holt, Sarah V ^a   Brookes, Karen E ^a   Dive, Caroline ^a,b   Makin, Guy W J ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Apoptosis; Cytotoxic agents; Paediatric cancer; XIAP

Indexed keywords

AEG 35156; CASPASE 3; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; VINCRISTINE; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CHEMOSENSITIZATION; DOWN REGULATION; ENZYME BLOOD LEVEL; EWING SARCOMA; HUMAN; HUMAN CELL; OSTEOSARCOMA; PEDIATRICS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; TUMOR CELL;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; BONE NEOPLASMS; CHILD; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; HUMANS; OLIGONUCLEOTIDES; OSTEOSARCOMA; RHABDOMYOSARCOMA; SARCOMA, EWING'S; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; VINCRISTINE; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 79952230990     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1167     Document Type: Article

References (21)

1. Gatta G, Capocaccia R, Stiller C, et al: Childhood cancer survival trends in Europe: a EUROCARE working group study. J Clin Oncol 23: 3742-3751, 2005.
2. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
3. Chai J, Wu Q, Shiozaki E, Srinivasula SM, Alnemri ES and Shi Y: Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding. Cell 107: 399-407, 2001. (Pubitemid 33049982)
4. Riedl SJ, Renatus M, Schwarzenbacher R, et al: Structural basis for the inhibition of caspase-3 by XIAP. Cell 104: 791-800, 2001. (Pubitemid 32241028)
5. Shiozaki EN, Chai J, Rigotti DJ, et al: Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 11: 519-527, 2003. (Pubitemid 36293842)
6. Liston P, Fong WG, Kelly NL, et al: Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol 3: 128-133, 2001. (Pubitemid 32118365)
7. Tamm I, Richter S, Scholz F, et al: XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis. Hematol J 5: 489-495, 2004. (Pubitemid 40045282)
8. Hu Y, Cherton-Horvat G, Dragowska V, et al: Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res 9: 2826-2836, 2003. (Pubitemid 36842129)
9. Vogler M, Walczak H, Stadel D, et al: Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma. Cancer Res 69: 2425-2434, 2009.
10. Shaw TJ, Lacasse EC, Durkin JP and Vanderhyden BC: Down-regulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo. Int J Cancer 122: 1430-1434, 2008. (Pubitemid 351287247)
11. Loeder S, Drensek A, Jeremias I, Debatin KM and Fulda S: Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for CD95-induced apoptosis. Int J Cancer 126: 2216-2228, 2010.
12. McManus DC, Lefebvre CA, Cherton-Horvat G, et al: Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene 23: 8105-8117, 2004. (Pubitemid 39531851)
13. LaCasse EC, Cherton-Horvat GG, Hewitt KE, et al: Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis. Clin Cancer Res 12: 5231-5241, 2006. (Pubitemid 44453353)
14. Hussein D, Estlin EJ, Dive C and Makin GW: Chronic hypoxia promotes hypoxia-inducible factor-1 alpha-dependent resistance to etoposide and vincristine in neuroblastoma cells. Mol Cancer Ther 5: 2241-2250, 2006. (Pubitemid 44530461)
15. Fakler M, Loeder S, Vogler M, et al: Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome bcl-2-mediated resistance. Blood 113: 1710-1722, 2009.
16. Tamm I, Kornblau SM, Segall H, et al: Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796-1803, 2000. (Pubitemid 30305074)
17. Haberler C, Slave I, Czech T, et al: Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome. Eur J Cancer 42: 2996-3003, 2006. (Pubitemid 44755258)
18. Potts PR, Singh S, Knezek M, Thompson CB and Deshmukh M: Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis. J Cell Biol 163: 789-799, 2003. (Pubitemid 37517886)
19. Dasgupta A, Alvarado CS, Xu Z and Findley HW: Expression and functional role of inhibitor-of-apoptosis protein livin (BIRC7) in neuroblastoma. Biochem Biophys Res Commun 400: 53-59, 2010.
20. Schimmer AD, Welsh K, Pinilla C, et al: Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell 5: 25-35, 2004. (Pubitemid 38121594)
21. Wang Z, Cuddy M, Samuel T, et al: Cellular, biochemical, and genetic analysis of mechanism of small molecule IAP inhibitors. J Biol Chem 279: 48168-48176, 2004. (Pubitemid 39540972)